News

Published on 6 Nov 2023 on Benzinga

Stocks Fight To Extend Winning Streak, Treasury Yields Rise: What's Driving Markets Monday? -...


Article preview image

The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space. Some mega-cap techs gained ground in the premarket, which bodes well for the broader market. A Fed speech scheduled for the day could also lend direction to the market. Notwithstanding the upside in the past week, analysts remain guarded as they lament the lack of breadth in the rally.

The uptick in bond yields at the start of the week may also cause uneasiness among traders.

NASDAQ.SANM price evolution
NYSE.XLU price evolution
NYSE.XLI price evolution
NASDAQ.MTTR price evolution
NYSE.XLE price evolution
NYSE.XLV price evolution
NASDAQ.VRTX price evolution
NASDAQ.TRIP price evolution
NASDAQ.BNTX price evolution
NYSE.XLRE price evolution
NASDAQ.OPK price evolution
NASDAQ.ICUI price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its...

As you might know, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) just kicked off its latest q...

Simply Wall St. via Yahoo Finance 9 May 2024

Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets

In this article, we will discuss the 10 stocks whose price targets were recently raised by analys...

Insider Monkey via Yahoo Finance 8 May 2024

Vertex shares target raised by RBC on robust CF sales By Investing.com

On Tuesday, RBC (TSX:RY) Capital Markets adjusted its price target for Vertex Pharmaceuticals...

Investing.com 7 May 2024

Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales

Vertex Pharmaceuticals Incorporated VRTX reported first-quarter 2024 adjusted earnings per share ...

Zacks via Yahoo Finance 7 May 2024

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Ve...

Insider Monkey via Yahoo Finance 7 May 2024

Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies

Vertex Pharmaceuticals Incorporated VRTX announced that it has entered into a licensing and colla...

Zacks via Yahoo Finance 23 Apr 2024

10 Best Performing Biotech ETFs in 2024

In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our ...

Insider Monkey via Yahoo Finance 22 Apr 2024

Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug

Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has granted a rolling new drug ap...

Zacks via Yahoo Finance 19 Apr 2024

Vertex starts rolling submission for non-opioid pain therapy

Vertex Pharmaceuticals (VRTX) stock gains as it begins marketing submission for its non-opioid pa...

Seeking Alpha 18 Apr 2024

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. S...

Zacks via Yahoo Finance 15 Apr 2024